p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women

Multiple Biopsies and Detection of Cervical Cancer Precursors at Colposcopy

(2015) Nicolas Wentzensen et al.   JOURNAL OF CLINICAL ONCOLOGY

Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening

(2014) Nicolas Wentzensen et al.   CANCER CYTOPATHOLOGY

Five-Year Experience of Human Papillomavirus DNA and Papanicolaou Test Cotesting

(2014) Philip E. Castle et al.   OBSTETRICS AND GYNECOLOGY

Interlaboratory variation in the performance of liquid-based cytology: Insights from the ATHENA trial

(2013) Thomas C. Wright et al.   INTERNATIONAL JOURNAL OF CANCER

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

(2013) L. Stewart Massad et al.   Journal of Lower Genital Tract Disease

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

(2013) Hormuzd A. Katki et al.   Journal of Lower Genital Tract Disease

Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study

(2013) Hans Ikenberg et al.   JNCI-Journal of the National Cancer Institute

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

(2012) Debbie Saslow et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Performance of p16/Ki-67 Immunostaining to Detect Cervical Cancer Precursors in a Colposcopy Referral Population

(2012) N. Wentzensen et al.   CLINICAL CANCER RESEARCH

Triage of HPV-positive women in cervical cancer screening

(2012) Nicolas Wentzensen   LANCET ONCOLOGY

Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial

(2012) Francesca Carozzi et al.   LANCET ONCOLOGY

Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts

(2011) Vikrant V Sahasrabuddhe et al.   Future Microbiology

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology

(2011) K. Ulrich Petry et al.   GYNECOLOGIC ONCOLOGY

Human Papillomavirus Testing in the Prevention of Cervical Cancer

(2011) Mark Schiffman et al.   JNCI-Journal of the National Cancer Institute

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

(2011) Hormuzd A Katki et al.   LANCET ONCOLOGY

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

(2011) Philip E Castle et al.   LANCET ONCOLOGY

HPV Screening for Cervical Cancer in Rural India

(2009) Rengaswamy Sankaranarayanan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial

(2008) Francesca Carozzi et al.   LANCET ONCOLOGY